There are no products in your shopping cart.
This section covers:
Human papillomavirus (HPV) primary screening, which is sometimes known as primary HPV testing, is a new way of examining cervical screening (smear test) samples. This method was trialled at six test sites in England by the NHS England Cervical Screening Programme. The trial was successful and in July 2016 it was announced that HPV primary screening will be rolled out across the whole of England by the end of 2019 . The Welsh Government announced that they will also be moving to HPV primary screening from late 2018. In Scotland, HPV primary screening will be rolled out in 2019/2020.
You can find out more about these HPV testing techniques and where in the UK they are used on our HPV testing page.
In both HPV triage and test of cure the sample of cells that was collected during your cervical screening appointment is tested for high-risk HPV after it has been examined under a microscope (cytology). With HPV primary screening the sample of cells is tested for high-risk HPV first. Cervical screening (smear) appointments will happen in exactly the same way they currently do all that will change is how the sample of cells is examined once it is sent off to the lab.
If high-risk HPV is not found, which would give a negative HPV test result, then you are safe to return to the normal screening programme. This is because without having a high-risk HPV infection there is virtually no chance of a woman going on to develop cervical cancer before her next test is due.
If high-risk HPV is found (HPV positive result) then cytology will be done to confirm if cell changes are present. If abnormal cells are seen under the microscope (abnormal cytology) you will be referred to colposcopy. If there are no abnormal cells (normal cytology) you will be screened again in 12 months. In this rescreening your cells will again be tested for high-risk HPV first before cytology. Around four out of every ten people (40%) affected by a high-risk HPV infection will clear it within 12 months and this increases to six out of every ten people (60%) within two years . This is why it is better to wait for 12 months and rescreen women who are positive for high-risk HPV but negative for abnormalities, because they may well clear the infection during this time without any abnormal cells developing, meaning no treatment will be needed.
The figure below outlines how the full process of HPV primary screening works .
If you are a health care professional involved in smear taking, please visit our Information for Practice Nurses and GPs pages where you will find a wide range of content, best practice guidelines, relevant links for you and your patients, and resources and ways that we can support you. You can also sign up for our quarterly health care professional e-newsletter.